Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19

Viruses
Kenneth Lundstrom

Abstract

Viral vectors can generate high levels of recombinant protein expression providing the basis for modern vaccine development. A large number of different viral vector expression systems have been utilized for targeting viral surface proteins and tumor-associated antigens. Immunization studies in preclinical animal models have evaluated the elicited humoral and cellular responses and the possible protection against challenges with lethal doses of infectious pathogens or tumor cells. Several vaccine candidates for both infectious diseases and various cancers have been subjected to a number of clinical trials. Human immunization trials have confirmed safe application of viral vectors, generation of neutralizing antibodies and protection against challenges with lethal doses. A special emphasis is placed on COVID-19 vaccines based on viral vectors. Likewise, the flexibility and advantages of applying viral particles, RNA replicons and DNA replicon vectors of self-replicating RNA viruses for vaccine development are presented.

References

Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R D Cone, R C Mulligan
Jul 8, 1999·Nature Medicine·H YingN P Restifo
Mar 13, 2003·World Journal of Gastroenterology : WJG·Wei LiangFan-Juan Meng
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Darren R ShafrenRichard D Barry
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kosei HasegawaKah-Whye Peng
Jul 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert J DursoWilliam C Olson
Jan 16, 2008·The Journal of Experimental Medicine·Rafick-Pierre Sekaly
Jul 25, 2008·International Journal of Cancer. Journal International Du Cancer·Ann-Marie MäättäJarmo Wahlfors
Nov 1, 2008·The Prostate·Pavlos MsaouelEvanthia Galanis
Feb 10, 2009·Vaccine·Franck Lemiale, Nikolay Korokhov
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators

❮ Previous
Next ❯

Citations

Jan 15, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kenneth Lundstrom
Mar 6, 2021·Expert Review of Vaccines·Kristina Jonsson-SchmunkMaria A Croyle
Mar 7, 2021·Viruses·Kenneth Lundstrom
Apr 20, 2021·Current Infectious Disease Reports·Arun KumarPaul A Kristiansen
Jul 3, 2021·Pathogens·Zainalabideen A AbdullaMohammad Z Abdulazeez
Nov 23, 2021·Pharmaceutical Development and Technology·Thuy Trang NguyenGiau Van Vo

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
xenografts
biopsies

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

International Journal of Molecular Sciences
Kenneth Lundstrom
Current Opinion in Biotechnology
Yuri Y GlebaSylvestre Marillonnet
Methods in Molecular Biology
Kenneth Lundstrom
Methods in Molecular Biology
Kenneth Lundstrom
© 2021 Meta ULC. All rights reserved